Mustafa Nevzat Pharmaceutical, which has been serving public health for nearly a century, was acquired by Amgen Pharmaceuticals in 2012. In 2020, it adopted the name Gensenta, facilitating patient access to medicines through its efforts to provide new and comprehensive solutions to a wider range of patients. Gensenta continued its operations as an Eczacıbaşı Group company in November 2022.